| Adjuvant trastuzumab emtansine versus paclitaxel in combination with trastuzumab for stage I HER2-positive breast cancer (ATEMPT): a randomized clinical trial SM Tolaney, N Tayob, C Dang, DA Yardley, SJ Isakoff, V Valero, ... Journal of Clinical Oncology 39 (21), 2375-2385, 2021 | 107 | 2021 |
| Trajectories of fear of cancer recurrence in young breast cancer survivors L Schapira, Y Zheng, SI Gelber, P Poorvu, KJ Ruddy, RM Tamimi, ... Cancer 128 (2), 335-343, 2022 | 48 | 2022 |
| Pregnancy after breast cancer: Results from a prospective cohort of young women with breast cancer PD Poorvu, SI Gelber, Y Zheng, KJ Ruddy, RM Tamimi, J Peppercorn, ... Cancer 127 (7), 1021-1028, 2021 | 32 | 2021 |
| Association of local therapy with quality-of-life outcomes in young women with breast cancer L Dominici, J Hu, Y Zheng, HJ Kim, TA King, KJ Ruddy, RM Tamimi, ... JAMA surgery 156 (10), e213758-e213758, 2021 | 24 | 2021 |
| Chemotherapy-related amenorrhea (CRA) after adjuvant ado-trastuzumab emtansine (T-DM1) compared to paclitaxel in combination with trastuzumab (TH)(TBCRC033: ATEMPT Trial) KJ Ruddy, Y Zheng, N Tayob, J Hu, CT Dang, DA Yardley, SJ Isakoff, ... Breast Cancer Research and Treatment 189 (1), 103-110, 2021 | 21 | 2021 |
| Switching warfarin to direct oral anticoagulants in atrial fibrillation: insights from the NCDR PINNACLE registry CT Sciria, TM Maddox, L Marzec, B Rodwin, SS Virani, A Annapureddy, ... Clinical Cardiology 43 (7), 743-751, 2020 | 19 | 2020 |
| Partners of young breast cancer survivors: a cross-sectional evaluation of psychosocial concerns, coping, and mental health NA Borstelmann, S Rosenberg, S Gelber, Y Zheng, M Meyer, KJ Ruddy, ... Journal of psychosocial oncology 38 (6), 670-686, 2020 | 18 | 2020 |
| Body weight changes and associated predictors in a prospective cohort of young breast cancer survivors T Sella, Y Zheng, Z Tan‐Wasielewski, SM Rosenberg, PD Poorvu, ... Cancer 128 (17), 3158-3169, 2022 | 12 | 2022 |
| Surgical treatment after neoadjuvant systemic therapy in young women with breast cancer: results from a prospective cohort study HJ Kim, L Dominici, SM Rosenberg, Y Zheng, LM Pak, PD Poorvu, ... Annals of surgery 276 (1), 173-179, 2022 | 12 | 2022 |
| Psychosocial issues and quality of life of parenting partners of young women with breast cancer NA Borstelmann, TF Gray, S Gelber, S Rosenberg, Y Zheng, M Meyer, ... Supportive Care in Cancer 30 (5), 4265-4274, 2022 | 12 | 2022 |
| Cardiac outcomes of subjects on adjuvant trastuzumab emtansine vs paclitaxel in combination with trastuzumab for stage I HER2-positive breast cancer (ATEMPT) study (TBCRC033 … R Barroso-Sousa, P Tarantino, N Tayob, C Dang, DA Yardley, SJ Isakoff, ... NPJ Breast Cancer 8 (1), 18, 2022 | 11 | 2022 |
| Treatment-related amenorrhea in a modern, prospective cohort study of young women with breast cancer PD Poorvu, J Hu, Y Zheng, SI Gelber, KJ Ruddy, RM Tamimi, ... NPJ Breast Cancer 7 (1), 99, 2021 | 10 | 2021 |
| Abstract PD10-02: patient reported outcomes from the adjuvant trastuzumab emtansine (T-DM1) vs. paclitaxel+ trastuzumab (TH)(ATEMPT) trial (TBCRC 033) A Partridge, Y Zheng, S Rosenberg, R Gelber, S Gelber, W Barry, C Dang, ... Cancer Research 80 (4_Supplement), PD10-02-PD10-02, 2020 | 7 | 2020 |
| Abstract PD18-01: Adjuvant trastuzumab emtansine versus paclitaxel plus trastuzumab for stage I HER2+ breast cancer: 5-year results and correlative analyses from ATEMPT (TBCRC033) P Tarantino, N Tayob, CT Dang, D Yardley, SJ Isakoff, V Valero, ... Cancer Research 83 (5_Supplement), PD18-01-PD18-01, 2023 | 4 | 2023 |
| Treatment discontinuation, patient-reported toxicities and quality-of-life by age following trastuzumab emtansine or paclitaxel/trastuzumab (ATEMPT) T Sella, Y Zheng, N Tayob, KJ Ruddy, RA Freedman, C Dang, D Yardley, ... NPJ Breast Cancer 8 (1), 127, 2022 | 4 | 2022 |
| Adjuvant endocrine therapy non-initiation and non-persistence in young women with early-stage breast cancer SM Rosenberg, Y Zheng, S Gelber, KJ Ruddy, P Poorvu, T Sella, ... Breast Cancer Research and Treatment 197 (3), 547-558, 2023 | 3 | 2023 |
| Association of tumor-infiltrating lymphocytes (TILs) with clinicopathologic characteristics and prognosis in young women with HR+/HER2-breast cancer (BC). ME Tesch, YD Guzman Arocho, LC Collins, J Heng, Y Zheng, N Tayob, ... Journal of Clinical Oncology 41 (16_suppl), 505-505, 2023 | 2 | 2023 |
| Fertility Preferences and Practices Among Young Women With Breast Cancer: Germline Genetic Carriers Versus Noncarriers R Lewinsohn, Y Zheng, SM Rosenberg, KJ Ruddy, RM Tamimi, ... Clinical breast cancer 23 (3), 317-323, 2023 | 2 | 2023 |
| Abstract P2-13-17: Fertility concerns and treatment decision-making among young women with breast cancer E Etaix, Y Zheng, S Rosenberg, KJ Ruddy, JR Hoverman, KM Emmons, ... Cancer Research 80 (4_Supplement), P2-13-17-P2-13-17, 2020 | 2 | 2020 |
| Granulocyte–Macrophage Colony-Stimulating Factor Influence on Soluble and Membrane-Bound ICOS in Combination with Immune Checkpoint Blockade X Li, J Li, Y Zheng, SJ Lee, J Zhou, A Giobbie-Hurder, LH Butterfield, ... Cancer immunology research 11 (8), 1100-1113, 2023 | 1 | 2023 |
Ann PartridgeDana-Farber Cancer InstituteVerified email at dfci.harvard.edu
